IMS Health RX
-
Medtronic's Revolutionary Device To Control High Blood Pressure
… Hypertension drugs, led by Novartis AG's ( NVS ) Diovan, totaled $13.9 billion globally in 2011, according to IMS Health , a market research firm. More than 42 million people take drugs to curb hypertension in the U.S. alone. 76 million …
-
New Issue- IMS Health sells $500 mln in notes
Oct 16 (Reuters) - IMS Health Inc on Tuesday sold $500 million of senior unsecured notes in the 144a private placement market, said IFR, a Thomson Reuters service. Goldman Sachs, Bank of America...
-
TEXT-S&P cuts IMS Health rating to 'B+'
Overview -- Health care information, services, and technology provider IMS Health Inc. is issuing an additional $1.25 billion of debt to fund a sponsor dividend of about $1.2 billion. -- Pro forma leverage …
-
BRIEF - Moody's rates new IMS Health bank debt Ba3
Oct 10 (Reuters) - Moody's rates new IMS Health bank debt Ba3
-
Smart Stocks Watch: Apricus Biosciences
… subsidiary of Apricus Bio -- an undisclosed upfront payment and milestone payments of up to €35 million. According to IMS Health , the United Kingdom represents the second-largest erectile dysfunction market in Europe, affecting Complete Story …
-
Emerging Nations: A Blossoming Field For Drug and Medical-Device Firms
… heating up in the emerging nations. The emerging nations currently account for 20% of all drug sales, according to IMS Health . And it’s forecast that drug sales there will rise 85% by 2016, to $359 billion from $194 billion in 2011; that …
-
French drugs market to shrink in 2012 - study
PARIS, March 29 (Reuters) - France's drugs market is set to shrink in 2012 for the first time, hit by government austerity measures to curb healthcare spending, according to a study published by pharmaceutical intelligence firm IMS Health .
-
UPDATE 1-IMS revises Incivek drug data; Vertex shares jump
Oct. 13 (Reuters) - IMS Health , which provides prescription data and other services to the pharmaceutical industry, said it is revising estimates of the number …
-
Generic Drugs Continue To Challenge Big Pharma
… decade. It commissioned an independent study, which was conducted by the IMS Institute for Healthcare Informatics and IMS Health . The report will no doubt get attention on Capital Hil and the GPhA is already calling on the budget "Super Committee …
-
PPD Names New CEO
… Raymond H. Hill joined PPD as chief executive officer and a member of the board last week. He previously was president of IMS Health 's Consulting Group, which is a leading health-care industry consultant. Hill's experience as a consultant in …